Mar 3, 2025 · 29m · the-pitch
#100 When Investors Take the Hot Seat
Jake Chapman · 8m spoken Josh Muccio · 6m spoken Howie Diamond · 4m spoken Jillian Manus · 2m spoken Daniel Gulati · 1m spoken Charles Hudson · 53s spoken
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this milestone 100th episode of The Pitch, former panel investors Jake Chapman and Howie Diamond step into the hot seat to pitch their new venture fund, Alpha Bridge Ventures, followed by a three-year retrospective examining their fundraising journey and strategic evolution.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Josh holds 26.5% of the talking time here. How this is scored →
Josh as informed peer 4.0 Guest teaching 2.5 Guest disagreement 3.0 Josh pushing back 3.8
speaking balance: gold is Josh, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 14:40 Jillian clashes with Howie over branding semantics
Jillian directly tells Howie 'You're wrong' and insists that the negative connotation of bridge rounds is an issue of LP optics rather than trivial semantics.
Hardest push from Josh ▶ 10:23 Daniel challenges rigid stage definitionsDaniel pushes back on Howie's dogmatic stage focus, arguing that great early-stage investing shouldn't be boxed in by rigid bridge labels.
Biggest teaching moment ▶ 11:51 Charles explains LP lag to HowieCharles draws on his Precursor Ventures experience to educate Howie on why fighting nomenclature battles with lagging LPs wastes unnecessary capital and effort.
Josh holds their own ▶ 23:18 Josh points out seed portfolio realityJosh sharpens the post-mortem by demonstrating that 20 of their 40 investments were actually seed rounds, proving the pitch panel's original critique accurate.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Josh as informed peer | Guest teaching | Guest disagreement | Josh pushing back | Why |
|---|---|---|---|---|---|---|
| Pitching Alpha Bridge Ventures and Post-Seed Thesis | 4 | 1 | 1 | 1 | Jake and Howie introduce the thesis for Alpha Bridge Ventures, focusing on post-seed bridge rounds. Josh provides host narration explaining the mechanics and stigma traditionally associated with bridge financing. | |
| Addressing Adverse Selection with Founder Wellness Programs | 4 | 2 | 3 | 4 | Daniel Gulati raises the classic adverse selection issue with bridge rounds. Jake and Howie address this by presenting their founder mental and physical wellness platform as their unfair competitive advantage for deal access. | |
| Debating Stage Dogmatism and Bridge Round Nomenclature | 4 | 4 | 6 | 6 | Daniel and Jillian challenge Howie on his rigid refusal to invest at the seed stage and argue the bridge label creates a negative stigma. Howie pushes back firmly, maintaining that bridge rounds offer superior derisked metrics compared to speculative seed rounds. | |
| Evaluating Fund Target and Receiving LP Feedback | 3 | 5 | 5 | 6 | Jillian praises the founder support program but firmly declines investing if the fund is branded as bridge-focused, citing negative LP optics. Charles shares his own experience navigating LP stage perceptions to advise them against unnecessary dogmatism. | |
| Mid-Episode Recap and Three-Year Time Jump | 5 | 2 | 2 | 4 | Josh interviews Jake and Howie three years later to review their fund's actual performance. Josh notes that half their portfolio deals ended up being seed stage investments, showing they ultimately followed the room's advice. | |
| Atlas Wellness Success and Portfolio Performance Update | 4 | 1 | 1 | 2 | Jake explains the unexpected commercial success of spinning out the Atlas wellness platform as an independent entity. Howie and Jake reflect candidly on their feelings toward the grind of venture fundraising. |
Statements from this episode (14)
Chapman: Post-Seed Bridge Deals Outperformed Across Our Portfolios
“And it turned out that those deals were the best deals we invested in, like across our portfolio. So they were raising A-Rounds within six months, much higher valuations. The revenue was growing really quickly in all of those companies.”
Diamond: Bridge Rounds Include High-Performing Outliers, Not Just Distressed Startups
“There was a negative stigma attached to the term bridge, and now people are calling it post seed, seed extension, whatever. C two. There are companies that are in these bridge rounds that are distressed companies that are looking for an influx of capital to he…”
Diamond: Our Post-Seed Cohort Delivered 2X to 2.5X Markups in 12 Months
“And we started seeing this crazy performance From this particular cohort of companies that we were investing in, anywhere from like, two X to 2.5 X over the course of 12 months from when we invested to Series A.”
Gulati: Automatically Passes on Seed Bridge Deals as a New Investor
“As an, as a new investor into a bridge, like, I automatically pass on those deals just off of that bias.”
Chapman: Over Half of Founders Have Diagnosable Mental Health Issues
“It's 30% can be diagnosed with clinical depression. 30% can be diagnosed with ADHD. It's about 29% can be diagnosed with, like, problematic anxiety to, like, where a clinician would diagnose you with it. And there's some overlap that still ends up being, like,…”
Diamond: Alpha Bridge is earmarking $1M for founder wellness platform
“So we're earmarking a million dollars from the fund we justify because we feel like we're gonna get into the best deals based on this program.”
Diamond: Alpha Bridge will not invest in seed rounds
“We start building the relationship in the seed. We won't invest, but we'll start building rapport with the founder.”
Manus: Branding around bridge rounds boxes a VC fund into a corner
“I think putting yourself in a bridge is really actually boxing yourself in. To a corner that I don't think you guys need to be there.”
Manus: Waiting until right before Series A prevents access to top deals
“I don't think you're going to get into really any of the good companies by just waiting that late right before the A to any of the companies.”
Chapman: Alpha Bridge will access hot deals via founder wellness support
“So I think we won't have trouble getting into deals that are hot deals because of the value add we're bringing. I think that that really does move the needle with founders.”
Hudson: Early-stage funds should adjust stage boundaries rather than stay rigid
“Like your job is to be in on the first institutional role these companies raise. And like you, the answer doesn't have to be, you'll do it a hundred percent of the time, but you should move the slider.”
Chapman: Alpha Bridge deployed 80-90% of capital into post-seed
“Yeah, I mean, it was, it's half and half based on number of investments, but it is, you know, 9010 or 80 20 in terms of capital deployed.”
Chapman: A defined niche drives VC deal flow and branding
“The other thing that's important to think about as a fund manager that I don't think is obvious is that even if the best strategy is to invest in pre-seed, seed, and post-seed, there is a lot of value to, at least from the external perspective, having a really…”
Alpha Bridge spun out founder wellness initiative Atlas into standalone business
“What we ended up doing was we spun it out as a separate business. We've had firms, other firms reach out and say, can we send our founders through Atlas? And so we started partnering with other venture firms, or we're taking their founders.”